| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |